Pub. Date : 2003 Sep
PMID : 12969536
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | RESULTS: After a week of Sandostatin therapy,the concentration of VEGF and bFGF in serum was drastically diminished (VEGF:1.02+/-0.41 microg /L vs 1.88+/-0.87 microg/L, P< 0.05;bFGF:0.88+/-0.32 ng/L vs 2.12+/-1.06 ng/L,P< 0.05). | Octreotide | vascular endothelial growth factor A | Homo sapiens |
| 2 | RESULTS: After a week of Sandostatin therapy,the concentration of VEGF and bFGF in serum was drastically diminished (VEGF:1.02+/-0.41 microg /L vs 1.88+/-0.87 microg/L, P< 0.05;bFGF:0.88+/-0.32 ng/L vs 2.12+/-1.06 ng/L,P< 0.05). | Octreotide | vascular endothelial growth factor A | Homo sapiens |
| 3 | CONCLUSION: By the short-term therapy of sandostatin, the expression of VEGF and bFGF can be inhibited. | Octreotide | vascular endothelial growth factor A | Homo sapiens |